Name: SENSORION SA (ALSEN) Stock
Brand: SENSORION SA
Rating: 4.5 (3 reviews)

Question 1

What does SENSORION SA do?

Accepted Answer

Sensorion SA is a biopharmaceutical company, which engages in the development of therapies to treat and prevent diseases of the inner ear such as deafness, vertigo, and tinnitus. The company is headquartered in Montpellier, Occitanie and currently employs 68 full-time employees. The company went IPO on 2015-04-21. The firm is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The firm develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.

Question 2

Can you provide the latest stock price for SENSORION SA?

Accepted Answer

The current stock price of ALSEN.PA is 0.335 EUR. The price increased by 1.82% in the last trading session.

Question 3

What is the dividend status of SENSORION SA?

Accepted Answer

ALSEN.PA does not pay a dividend.

Question 4

What is the ChartMill technical and fundamental rating of ALSEN stock?

Accepted Answer

ALSEN.PA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.

Question 5

What is the market capitalization of ALSEN stock?

Accepted Answer

SENSORION SA (ALSEN.PA) has a market capitalization of 100.72M EUR. This makes ALSEN.PA a Micro Cap stock.

Question 6

When does SENSORION SA (ALSEN.PA) report earnings?

Accepted Answer

SENSORION SA (ALSEN.PA) will report earnings on 2026-03-12, after the market close.

SENSORION SA (ALSEN.PA) Stock Price, Forecast & Analysis

ALSEN.PA Latest News, Press Relases and Analysis